Literature DB >> 22038572

Only C-reactive protein, but not TNF-α or IL6, reflects the improvement in inflammation after bariatric surgery.

Eva Pardina1, Roser Ferrer, Juan Antonio Baena-Fustegueras, Joaquín Rivero, Albert Lecube, Jose Manuel Fort, Víctor Vargas, Roberto Catalán, Julia Peinado-Onsurbe.   

Abstract

BACKGROUND: Increased C-reactive protein (CRP) levels strongly predict inflammatory diseases such as obesity and tissue damage. We wanted to study the CRP in plasma and tissue in morbidly obese patients before and after surgery and relate it with the expression of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in tissues.
METHODS: We analyzed CRP concentration in plasma, adipose and liver, and the expression of IL-6 and TNF-α, in those tissues, in 34 morbidly obese patients before and 1, 6 and 12 months after gastric bypass.
RESULTS: Morbidly obese had a greater amount of CRP in plasma (3 times) and tissues (21, 5 and 7 times more in liver, subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT), respectively) than control subjects. The expression of IL-6 in SAT showed a similar profile to plasma and SAT CRP in both obese patients and after weight loss, despite no significant correlation was found. We were only able to detect IL-6 in the liver of a subset of patients. The expression of TNF-α after surgery showed a no significant slight tendency to decrease in SAT with weight loss, but in the liver, we did not observe any change.
CONCLUSION: IL-6 in SAT, but not in liver, seems to be more closely related to plasma and tissue CRP than TNF-α in both obese patients and after weight loss. Plasma CRP protein perfectly reflects the decrease in inflammation and improves with weight loss in the tissues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22038572     DOI: 10.1007/s11695-011-0546-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  29 in total

1.  Differentiation between obesity and insulin resistance in the association with C-reactive protein.

Authors:  Tracey McLaughlin; Fahim Abbasi; Cindy Lamendola; Lynn Liang; Gerald Reaven; Patricia Schaaf; Peter Reaven
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

2.  Body mass index as a measure of body fatness: age- and sex-specific prediction formulas.

Authors:  P Deurenberg; J A Weststrate; J C Seidell
Journal:  Br J Nutr       Date:  1991-03       Impact factor: 3.718

3.  C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites.

Authors:  J C Chambers; S Eda; P Bassett; Y Karim; S G Thompson; J R Gallimore; M B Pepys; J S Kooner
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

4.  Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue.

Authors:  John N Fain; Suleiman W Bahouth; Atul K Madan
Journal:  Biochem Pharmacol       Date:  2005-05-01       Impact factor: 5.858

5.  Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians.

Authors:  Byambaa Enkhmaa; Kuninori Shiwaku; Erdembileg Anuurad; Akiko Nogi; Keiko Kitajima; Masayuki Yamasaki; Tsendsuren Oyunsuren; Yosuke Yamane
Journal:  Clin Chim Acta       Date:  2005-02       Impact factor: 3.786

6.  Association between C-reactive protein and features of the metabolic syndrome: a population-based study.

Authors:  M Fröhlich; A Imhof; G Berg; W L Hutchinson; M B Pepys; H Boeing; R Muche; H Brenner; W Koenig
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

7.  Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors.

Authors:  S Müller; S Martin; W Koenig; P Hanifi-Moghaddam; W Rathmann; B Haastert; G Giani; T Illig; B Thorand; H Kolb
Journal:  Diabetologia       Date:  2002-05-08       Impact factor: 10.122

8.  Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.

Authors:  Alicia H Clementi; Allison M Gaudy; Nico van Rooijen; Robert H Pierce; Robert A Mooney
Journal:  Biochim Biophys Acta       Date:  2009-08-20

9.  Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements?

Authors:  E Bonora; R Micciolo; A A Ghiatas; J L Lancaster; A Alyassin; M Muggeo; R A DeFronzo
Journal:  Metabolism       Date:  1995-12       Impact factor: 8.694

10.  Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe.

Authors:  Armin Imhof; Margit Fröhlich; Hannelore Loewel; Nicole Helbecque; Mark Woodward; Phillipe Amouyel; Gordon D O Lowe; Wolfgang Koenig
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

View more
  32 in total

1.  The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans.

Authors:  Derek K Hagman; Ilona Larson; Jessica N Kuzma; Gail Cromer; Karen Makar; Katya B Rubinow; Karen E Foster-Schubert; Brian van Yserloo; Peter S Billing; Robert W Landerholm; Matthew Crouthamel; David R Flum; David E Cummings; Mario Kratz
Journal:  Metabolism       Date:  2017-02-02       Impact factor: 8.694

Review 2.  Does bariatric surgery improve adipose tissue function?

Authors:  H Frikke-Schmidt; R W O'Rourke; C N Lumeng; D A Sandoval; R J Seeley
Journal:  Obes Rev       Date:  2016-06-08       Impact factor: 9.213

Review 3.  More than an Anti-diabetic Bariatric Surgery, Metabolic Surgery Alleviates Systemic and Local Inflammation in Obesity.

Authors:  Chunlan Zhang; Jingjing Zhang; Zhenqi Liu; Zhiguang Zhou
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

Review 4.  Recent advances in the modification of taste and food preferences following bariatric surgery.

Authors:  Stefany D Primeaux; Taniya de Silva; Tony H Tzeng; Monica C Chiang; Daniel S Hsia
Journal:  Rev Endocr Metab Disord       Date:  2016-06       Impact factor: 6.514

Review 5.  Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery.

Authors:  Xi Chen; Jingjing Zhang; Zhiguang Zhou
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

6.  Impact of Intragastric Balloon Treatment on Adipokines, Cytokines, and Metabolic Profile in Obese Individuals.

Authors:  Marcella Rodrigues Guedes; Ricardo José Fittipaldi-Fernandez; Cristina Fajardo Diestel; Márcia Regina Simas Torres Klein
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

7.  Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery.

Authors:  Christos G Galanakis; Markos Daskalakis; Andreas Manios; Argyro Xyda; Apostolos H Karantanas; John Melissas
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

8.  Effects of thiol antioxidant β-mercaptoethanol on diet-induced obese mice.

Authors:  Siu Wong; James L Kirkland; Heidi A Schwanz; Amber L Simmons; James A Hamilton; Barbara E Corkey; Wen Guo
Journal:  Life Sci       Date:  2014-05-05       Impact factor: 5.037

9.  De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.

Authors:  Leah Eissing; Thomas Scherer; Klaus Tödter; Uwe Knippschild; Jan Willem Greve; Wim A Buurman; Hans O Pinnschmidt; Sander S Rensen; Anna M Wolf; Alexander Bartelt; Joerg Heeren; Christoph Buettner; Ludger Scheja
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α. Prospective clinical trial.

Authors:  Elaine Cristina Viana; Karine L Araujo-Dasilio; Gustavo Peixoto Soares Miguel; Josefina Bressan; Elenice Moreira Lemos; Margareth Ribeiro Moyses; Gláucia Rodrigues de Abreu; João Luiz Moreira Coutinho de Azevedo; Perseu Seixas Carvalho; Maria Rita S Passos-Bueno; Flávia Imbroisi Valle Errera; Nazaré Souza Bissoli
Journal:  Obes Surg       Date:  2013-08       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.